Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Seminars in Nuclear Medicine
|
April 6, 2012
Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors
James C Sisson, Gregory A Yanik
AMA Journal of Ethics
|
October 26, 2019
How Should We Determine the Value of CAR T-Cell Therapy?
Sara Silbert, Gregory A Yanik, Andrew G Shuman
AJR. American Journal of Roentgenology
|
January 24, 2003
CT of renal lymphoma in children
Neeraj B Chepuri, Peter J Strouse, Gregory A Yanik
Blood Reviews
|
May 17, 2021
An owner's manual for CD19 "CAR"-T cell therapy in managing pediatric and young adult B-cell acute lymphoblastic leukemia
Theodore W Laetsch, Gregory A Yanik, Michael W Boyer, et al.
Pediatric Hematology and Oncology
|
June 19, 2015
Variation in Management of Fever and Neutropenia Among Pediatric Patients With Cancer: A Survey of Providers in Michigan
Emily L Mueller, Kelly J Walkovich, Gregory A Yanik, et al.
Clinical Nuclear Medicine
|
December 24, 2005
Radiation-induced osteosarcoma and papillary carcinoma of the thyroid
Adam Tonakie, Barry L Shulkin, James C Sisson, et al.
Seminars in Nuclear Medicine
|
April 13, 2016
¹³¹I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications
Marguerite T Parisi, Hedieh Eslamy, Julie R Park, et al.
Pediatric Blood & Cancer
|
August 13, 2017
An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes
Laura M Bou-Maroun, Fabien Meta, Curtis J Hanba, et al.
Journal of Experimental Therapeutics & Oncology
|
September 6, 2008
Bortezomib as a therapeutic candidate for neuroblastoma
Michael B Armstrong, Kurt R Schumacher, Rajen Mody, et al.
Pediatric Blood & Cancer
|
August 11, 2015
Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome
Angela C Weyand, Gregory A Yanik, Nathanael G Bailey, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Seminars in Nuclear Medicine
|
April 6, 2012
Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors
James C Sisson, Gregory A Yanik
AMA Journal of Ethics
|
October 26, 2019
How Should We Determine the Value of CAR T-Cell Therapy?
Sara Silbert, Gregory A Yanik, Andrew G Shuman
AJR. American Journal of Roentgenology
|
January 24, 2003
CT of renal lymphoma in children
Neeraj B Chepuri, Peter J Strouse, Gregory A Yanik
Blood Reviews
|
May 17, 2021
An owner's manual for CD19 "CAR"-T cell therapy in managing pediatric and young adult B-cell acute lymphoblastic leukemia
Theodore W Laetsch, Gregory A Yanik, Michael W Boyer, et al.
Pediatric Hematology and Oncology
|
June 19, 2015
Variation in Management of Fever and Neutropenia Among Pediatric Patients With Cancer: A Survey of Providers in Michigan
Emily L Mueller, Kelly J Walkovich, Gregory A Yanik, et al.
Clinical Nuclear Medicine
|
December 24, 2005
Radiation-induced osteosarcoma and papillary carcinoma of the thyroid
Adam Tonakie, Barry L Shulkin, James C Sisson, et al.
Seminars in Nuclear Medicine
|
April 13, 2016
¹³¹I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications
Marguerite T Parisi, Hedieh Eslamy, Julie R Park, et al.
Pediatric Blood & Cancer
|
August 13, 2017
An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes
Laura M Bou-Maroun, Fabien Meta, Curtis J Hanba, et al.
Journal of Experimental Therapeutics & Oncology
|
September 6, 2008
Bortezomib as a therapeutic candidate for neuroblastoma
Michael B Armstrong, Kurt R Schumacher, Rajen Mody, et al.
Pediatric Blood & Cancer
|
August 11, 2015
Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome
Angela C Weyand, Gregory A Yanik, Nathanael G Bailey, et al.
Page
of 8